ADispell's mission is to take a patented discovery about the operation of signal receptors on brain neurons and other proprietary discoveries to advance identified lead drug compounds through development and clinical trial phases. Our in vivo results have indicated we are clearly on the right path.

You already know the reach and significance of this devastating disease. Current drugs have minimal impact on disease advancement.

ADispell will advance a platform technology that can be of significance to drug addiction and toxicity and cognitive loss diseases, as well as other behavior related conditions. The potential for the technology is far-reaching and deep. We consider investment and partnering opportunities with those who have passion to improve conditions while garnering a attractive financial return.

If this sounds of interest and you are a serious investor who would like to learn more, please contact us at info@adispell.com